TRAIP promotes malignant behaviors and correlates with poor prognosis in liver cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TRAIP promotes malignant behaviors and correlates with poor prognosis in liver cancer

Published:2020-04 Issue: Volume:124 Page:109857
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Guo Zhenya,Zeng Yonglian,Chen Yubing,Liu Mingjiang,Chen Shilian,Yao Mei,Zhang Peng,Zhong Fudi,Jiang Keqing,He Songqing,Yuan Guandou

Funder

Natural Science Foundation of Guangxi

National Natural Science Foundation of China

111 Projects

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference16 articles.

1. A TRIP back in time to TRIP;Bhat;J. Proteomics & Bioinformatics,2018

2. The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis;Chapard;Oncotarget,2015

3. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-κB activation;Lee;J. Exp. Med.,1997

4. The Tumor Suppressor CYLD Interacts with TRIP and Regulates Negatively Nuclear Factor κB Activation by Tumor Necrosis Factor;Regamey;J. Exp. Med.,2003

5. The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells;Zhou;Oncogene,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRAIP enhances progression of tongue squamous cell carcinoma through EMT and Wnt/β-catenin signaling by interacting with DDX39A;2024-04-25

2. TRAIP suppresses bladder cancer progression by catalyzing K48-linked polyubiquitination of MYC;Oncogene;2023-12-20

3. TRAIP suppressed apoptosis and cell cycle to promote prostate cancer proliferation via TRAF2–PI3K–AKT pathway activation;International Urology and Nephrology;2023-12-15

4. Implications of ubiquitination and the maintenance of replication fork stability in cancer therapy;Bioscience Reports;2023-10

5. TRAIP serves as a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma;International Immunopharmacology;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3